- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Toll-like Receptors in United Kingdom
Total 1659 results
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Wake Forest University Health SciencesJohns Hopkins UniversityTerminatedHIV | Sarcopenia | Aging | Angiotensin Receptor AntagonistsUnited States
-
Georgetown UniversityTyme, IncTerminatedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Breast CarcinomaUnited States
-
University College, LondonUniversity College London HospitalsCompletedQuality of Life | Precancerous Conditions | Patient Engagement | Patient Participation | Oral Disease | Patient Satisfaction | Health Behavior | Precancerous Lesions | Oral Leukoplakia | Dental Diseases | Oral Lichen Planus | Dysplasia | Patient Preference | Information Seeking Behavior | Oral Epithelial Dysplasia | Oral... and other conditionsUnited Kingdom
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCentral Line Complication | Central Line InfectionUnited States
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
University of NottinghamCompletedQuality of Life | Delirium | Prostatic Neoplasms | Surgery | Colorectal Carcinoma | Bladder Carcinoma | Colon Carcinoma | Impaired Cognition | Abdominal Hysterectomy (& Wertheim) | Renal CarcinomaUnited Kingdom
-
Case Comprehensive Cancer CenterWithdrawnStage I Breast Cancer | HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast... and other conditionsUnited States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Mayo ClinicRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
Oregon Research Behavioral Intervention Strategies...National Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Janssen Research & Development, LLCCompletedProstatic NeoplasmsUnited States, Canada
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Velindre NHS TrustCompletedMedullary Thyroid CancerUnited Kingdom
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Adult Solid NeoplasmUnited States
-
University of Alabama at BirminghamWithdrawn
-
Daiichi SankyoCompletedHER2-negative Breast Cancer | HER2-low Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingMetastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast CancervUnited States
-
Stemline Therapeutics, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
European Organisation for Research and Treatment...CompletedGastric CancerUnited Kingdom, France, Sweden, Germany, Spain
-
Stanford UniversityCompleted
-
University of California, San FranciscoCompletedEnd of Life CommunicationUnited States
-
Hackensack Meridian HealthCompleted
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
Centre de Recherche de l'Institut Universitaire...Canadian Institutes of Health Research (CIHR); Medical Research Council; Fonds... and other collaboratorsCompletedQuality of Life | Urinary Incontinence | Falls, Accidental | StigmaCanada, France, United Kingdom
-
Loulou FoundationActive, not recruitingCyclin-Dependent Kinase-Like 5 Deficiency DisorderUnited States, Spain, Italy, France, Canada, Germany, United Arab Emirates
-
Laureate Institute for Brain Research, Inc.National Institute of General Medical Sciences (NIGMS)CompletedAdolescents With Early Life StressUnited States
-
VA Office of Research and DevelopmentCompletedTerminal Conditions, End of LifeUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Elevated CA15-3 or CEA or CA27-29United States, Puerto Rico, Guam
-
Sun Pharma Advanced Research Company LimitedTerminatedAdvanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States, India
-
University of California, Los AngelesCompletedChild Overall Health Related Quality of LifeUnited States
-
OctapharmaCompletedPrimary ImmunodeficiencyUnited Kingdom, Australia, Germany, Italy
-
Ascension Genesys HospitalUniversity of Pennsylvania; Robert Wood Johnson FoundationCompleted
-
Kathy MillerGenentech, Inc.RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-low Breast CancerUnited States
-
US Department of Veterans AffairsCompleted
-
GTxTerminatedTriple Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Harvard School of Public Health (HSPH); Partners... and other collaboratorsCompleted
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States
-
Oklahoma State University Center for Health SciencesOklahoma State UniversityCompletedEmotional Dysfunction | Early Life StressUnited States
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, France, Australia, Canada, Spain, United Kingdom, Italy, Belgium
-
M.D. Anderson Cancer CenterRecruitingHealthy Lifestyle | Life StyleUnited States